Glenmark Pharma gets USFDA nod for erectile dysfunction treatment

Glenmark Pharmaceuticals Ltd has received final approval from the
United States Food and Drug Administration (USFDA) for Tadalafil
tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the
company said in a regulatory filing.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-erectile-dysfunction-treatment/articleshow/80040795.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation